Gen Med: Ednocrine > Type 2 DM > Flashcards

Type 2 DM Flashcards

(89 cards)

Study These Flashcards
1
Q

What are the general characteristics of T2DM?

A
  1. Occurs in adults, adolescents and children
  2. Circulating endogenous insulin is sufficient to prevent ketoacidosis but is inadequate to prevent hyperglycemia
  3. Genetics and environment combine to cause beta cell loss and insulin resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most important environmental factor contributing to insulin resistance?

A

Visceral obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What racial groups is T2DM more prevalent in?

A

African American, Native American, Hispanic American and Asian American populations in US compared w/ Caucasian Americans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What epidemiological trends are present in T2Dm?

A
  1. 39% pts with Type II DM have at least one parent w/ disease
  2. In identical twins with one affected, ~ 90% of unaffected twins eventually develop DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the risk factors for T2DM?

A
  1. Family Hx
  2. Ethnicity
    A. African Americans, Hispanics, Native Americans, Asian Americans
  3. Obesity
  4. Fat distribution
    A. Visceral fat → insulin resistance
  5. Lifestyle factors
    A. Sedentary lifestyle, smoking, OSA
  6. Metabolic Syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is metabolic syndrome asst with?

A

high risk of diabetes, cardiovascular disease & stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the underlying causes of metabolic syndrome?

A
  1. Obesity / overweight
  2. Physical inactivity
  3. Genetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define metabolic syndrome

A

3 or more of following parameters:

  1. Abdominal obesity
  2. Triglyceride level > 150 mg/dL
  3. HDL cholesterol < 40 mg/dL in men or < 50 mg/dL in women
  4. SBP ≥ 130
  5. Waist circumference > 40 in (males) and > 35 in (females)
  6. FBS ≥ 100 mg/dL
  7. Insulin resistance or glucose intolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are other insulin stimulating hormones?

A
  1. Incretin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the characteristics and function of incretin?

A
  1. Synthesized in ileum & colon in response to incoming nutrients
  2. Stimulate insulin secretion
  3. ↓ Glucagon secretion
  4. ↑ Beta cell survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the most important incretin hormone?

A

GLP-1

Secretion abnormal in impaired glucose tolerance (IGT) & Type II DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the actions of GLP-1?

A
  1. ↑ Glucose dependent insulin secretion
  2. Suppresses glucagon secretion
  3. Slows gastric emptying & promotes satiety
  4. ↑ Beta cell proliferation
  5. May improve insulin sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the sxs of T2DM?

A 
1. Asymptomatic
A. Most pts
2. Peripheral neuropathy
3. Blurred vision
4. Pruritis / skin infections
5. Candidal vaginitis
6. Acanthosis nigricans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define acanthosis nigricans

A

Hyperpigmented and hyperkeratotic skin in axilla, groin, & back of neck

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the urinalysis results in T2dm?

A
  1. Urinalysis
    A. Glycosuria
  2. Urine for micro-albumin
    A. Diabetic nephropathy

Baseline and annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the FBS for impaired glucose tolerance?

A

FBS 100-126 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the random glucose/2 hr GTT for DM?

A

Random glucose or 2 hr GTT ≥ 200 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What do you do if FBS > 126 mg/dL?

A 
1. F/U with 2 hr GTT
A. Impaired (pre-diabetes) → 2 hr  GTT 140-200 mg/dL
(-) test:
B. Fasting glucose < 100 mg/dL
C. 2 hr gluc < 140 mg/dL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the lipid abnormalities with T2DM?

A

T. chol > 200 mg/dL
Trig 300-400 mg/dL
HDL < 30 mg/dL
LDL > 100 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Why is an EKG performed for T2DM?

A

r/o CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why are BUN/Cr and electrolytes tested?

A

Diabetic nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the CHO diet recommendations for a T2DM?

A

45-65% total calories

Count carbs to titrate insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the fat diet recommendations for a T2DM?

A

25-35% with < 7% from sat fats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the protein diet recommendations for a T2DM?

A

10-35%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What are the cholesterol diet recommendations for a T2DM?
< 200 mg/day if LDL > 100 mg/dL
26
Why is dietary fiber recommended for a T2DM?
1. Slows nutrient absorption rates so glucose absorption is slower -> lowers hyperglycemia 2. Favorable affect on cholesterol
27
What immunizations are recommended for T2DM?
Influenza | Pneumococcal
28
What is the HTN goal for T2DM?
Goal < 140/90 mmHg
29
What drugs are used to treat and prevent diabetic nephropathy?
ACEI or ARB
30
What is the lipid goal for T2DM?
1. Goal LDL < 100 mg/dL | 2. Statin therapy (*)
31
What are the treatment recommendations for CAD/PAD risk?
1. Anti-platelet therapy | 2. ASA or clopidogrel (Plavix)
32
What are the classes of drugs for treating hyperglycemia?
``` 1. Oral secretogogues A. Sulfonylureas B. Meglitinide analogs C. D-Phenylalanine derivative 2. Biguanides 3. Thiazolidinediones (TZD’s) 4. Alpha glucosidase inhibitors 5. GLP-1 receptor agonists 6. DPP-4 inhibitors 7. Amylin analogs 8. Insulin ```
33
What is the moa and effects of sulfonyureas?
1. Stimulate insulin release from pancreatic islet beta cells 2. Bind to sulfonylurea receptor on beta cell 3. ↑ insulin / ↓ pp serum glucose
34
What are the se and contraindications of sulfonyureas?
1. Weight gain 2. Hypoglycemia A. ↑ risk w/ certain long acting preparations B. Glyburide/Micronase 3.Metabolized by liver & excreted by kidneys A. Contraindicated in pts with severe liver or kidney disease
35
What are the 1st generation sulfonyureas?
1. Rarely used today | 2. Includes Tolbutamide / Orinase, Clorpropamide / Diabenase
36
What are the 2nd generation sulfonyureas?
1. Glyburide / Micronase | 2. Glipizide / Glucotrol, Glucotrol XL
37
What is the moa and effects of meglitinide analogs?
1. MOA A. Stimulate insulin release from pancreatic islet beta cells 2. Physiologic Effects Rapid but brief ↑ insulin -> ↓ pp serum glucose
38
How are the meglitinides metabolized?
1. Completely metabolized by liver 2. Plasma half life < 1 hr A. Useful in pts w/ kidney disease
39
What are the se of meglitinides?
1. Weight gain | 2. Hypoglycemia – less effect than glyburide
40
What are examples of meglitinide analogs?
1. “…nide” drugs | 2. Repaglinide / Prandin
41
What is the moa and effects of D-phenylalanine derivatives?
1. MOA A. Stimulate insulin release from pancreatic islet beta cells 2. Physiologic Effects A. Rapid but brief ↑ insulin -> ↓ pp serum glucose
42
How are D-phenylalanine derivatives metabolized?
Completely metabolized by liver Plasma half life 1.5 hrs Useful in pts w/ kidney disease
43
What are the se of D-phenylalanine derivatives?
Weight gain | Hypoglycemia – less effect than Glyburide
44
What is an example of D-phenylalanine derivatives?
“….nide” drugs | Nateglinide / Starlix
45
What is the moa and effects of biguanides?
1. MOA A. ↑ number & affinity of insulin receptors in peripheral tissues B. ↓ hepatic glucose output C. ↓ glucose absorption from gut D. ↑ glucose uptake & utilization in skeletal muscle & adipose tissue 2. Effects A. ↓ serum glucose
46
How are biguanides metabolized?
Completely metabolized by kidneys
47
What is first line therapy in T2DM pts?
Biguanides | Metformin / Glucophage
48
What are the SE and contraindications of biguanides?
``` 1. SE A. GI upset, abdominal bloating B. DOES NOT cause hypoglycemia 2. Contraindications CHF A. Renal Insufficiency B. Hepatic Disease C. Metabolic (Lactic) D. Acidosis E. Excessive alcohol intake ```
49
What is the moa and effects of TZDs?
1. MOA A. Sensitize peripheral tissues to insulin  ↓ hepatic glucose production B. Dependent on presence of insulin for activity 2. Effects A. ↓ pp serum glucose B. ↓ triglyceride levels
50
What are the SE and contraindications for TZDs?
``` 1. SE A. Fluid retention B. CHF C. Weight gain D. DOES NOT cause hypoglycemia 2. Contraindications A. NYHA Failure Class III & Class IV B. Black box warning inc potential risk of MI Limited use ```
51
What are the TZDs?
“…zone” drugs Rosiglitzone / Avandia Pioglitazone / Actos
52
What is the moa and effects of alpha glucosidase inhibitors?
1. MOA A. Delays CHO absorption in gut 2. Physiologic Effects A. Delays digestion of carbohydrates, resulting in smaller ↑ pp serum glucose
53
What are the SE of Alpha glucosidase inhibitors?
1. Bloating & flatulence | A. Due to undigested CHO reaching large bowel
54
What are examples of alpha glucosidase inhibitors?
1. Acarbose / Precose | 2. Miglitol / Glyset
55
What are the incretins?
Intestinal hormones that stimulate insulin release due to elevated GI glucose Glucagon like peptide 1 (GLP-1) Glucose-dependent insulinotropic polypeptide (GIP)
56
What is the incretin effect in T2DM?
“Incretin effect” is reduced in pts with Type II DM
57
What is the half life of GLP-1
1. GLP-1 half life is 1-2 minutes A. Rapidly broken down by dipeptidyl peptidase 4 (DPP-4) B. As a result, GLP-1 receptor agonists were created
58
What is the moa nd effects of GLP-1 agonists?
``` 1. MOA A. Activates GLP-1 receptors B. Physiologic Effects C. ↑ insulin secretion D. Lower risk of hypoglycemia E. ↓ glucagon secretion F, Slows gastric emptying G. ↓ hunger H> Promotes weight loss ```
59
What are the SE of the GLP-1 agonists?
1. Reports of severe pancreatitis, renal impairment & ARF 2. DO NOT use in CKD 3. Black box warning - ↑ risk thyroid CA w/+ FH
60
What are examples of the GLP-1 agonists?
1. GLP-1 Receptor Agonists A. Liraglutide (Victoza) B. Exenatide (Byetta, Bydureon)
61
What is the moa and effects of DPP-4 inhibitors?
Alternative approach to GLP-1 Agonists ``` 1. MOA A. Slows incretin metabolism B. Inhibit DPP4 -> prolong action of GLP-1 & GIP 2. Physiologic effects: A. ↑ insulin secretion B. Promotes ↑ glucose uptake by muscle & adipose tissue C. ↓ glucagon secretion D. ↓circulating glucose ```
62
What are the SE of DPP-4 inhibitors?
``` 1. Most common A. URI 2. Less common A. Anaphylaxis B. Angioedema C. Stevens-Johnson Syndrome ```
63
What are examples of the Dpp-4 inhibitors?
``` 1. “…gliptin” drugs A. Sitagliptin (Januvia) B. Saxagliptin (Onglyza) C. Linagliptin (Tradjenta) D. Alogliptin (Nesina) ```
64
What is amylin and amyline analogs? Who are they used in?
1. Released from beta cells with insulin | 2. Used in Type I & Type II IDDM
65
What is the mechanism of action of amylin analogs?
1. ↓ pp glucose 2. Delays gastric emptying 3. Suppresses glucagon secretion 4. Promotes satiety
66
When are amylin analogs dosed?
1. Injected immediately before meals | A. Hypoglycemia may occur & w/delayed gastric emptying
67
What are the amylin analogs?
Pramlintide/Symlin
68
What are the effects of Canagloflozin/Invokana?
1. Inhibits Na-glucose cotransporter 2 2. ↓ glucose reabsorption in kidney 3. ↑ urine glucose excretion
69
What are the effects of bromocriptine/cycloset?
1. Resets circadian rhythm 2. Stimulates dopamine receptors, inhibits prolactin secretion by pituitary 3. ↓ fasting and PP hyperglycemia w/out ↑ insulin
70
When should screening for complications begin in T2DM? What does this include?
``` 1. Screening for complications should begin when DM diagnosed A. Ophthalmology referral -Fundoscopic exam B. Podiatry referral C. Urine for micro-albumin D. Serum creatinine, BUN, lytes E. Lipid profile F. BP G. EKG ```
71
What is the leading cause of new blindness in 25-65 yo?
1. Diabetic retinopathy | 2. 60% of DM patients develop retinopathy after 15-20yrs of DM
72
What are the sxs of diabetic retinopathy?
1. Cotton wool spots (areas of ischemic retina) with resulting atrophy of axons 2. Retinal hemorrhages 3. Neovascularization: A. Several small, friable new vessels forming around the optic disc. If these rupture, the hemorrhage can lead to blindness
73
How is diabetic retinopathy screened for?
1. urine for micro-albumin | A. Can detect diabetic nephropathy at earliest stages
74
What are the sxs of peripheral neuropathy?
1. Stocking glove paresthesia 2. Painless loss of sensation A. Touch, vibration, proprioception, temperature B. Leading to: Foot ulcers Destruction of foot architecture (Charcot Foot) Loss of DTR’s Muscle atrophy Foot drop
75
What are the sxs of diabetic neuropathy in the cardiovascular system?
``` 1. Orthostatic hypotension A. Loss of compensatory increase in HR 2. Exercise intolerance 3. Resting tachycardia 4. ***Silent MI*** ```
76
What are the sxs of diabetic neuropathy in the GI system?
1. Dysphagia, early satiety, delayed emptying (gastroparesis), vomiting after meals 2. Constipation, diarrhea, fecal incontinence
77
What are the sxs of diabetic neuropathy in the GU system?
1. Urinary incontinence/retention (neurogenic bladder) 2. Vaginal dryness 3. Erectile dysfunction (75% DM males by age 65)
78
What are the sxs of vascular complications in T2DM?
``` 1. CAD/MI A. Leading cause of mortality in Type II DM 2. Stroke/TIA 3. PAD A. Claudication B. Most common sx ```
79
What are the complications to the immune system in T2DM?
``` 1. Infections A. Mucocutaneous fungal infections B. Bacterial foot infections (most common) -Nonhealing ulcers -Gangrene -Osteomyelitis ```
80
What pt education needs to occur?
1. Diabetic educator, dietitian, close follow up 2. Home glucose monitoring 3. Signs/sx’s hypoglycemia/hyperglycemia & management 4. Early care for illness 5. Medic alert tag 6. Exercise 7. Wt loss 8. Risk of long term complications 9. Tight glucose control in most patients
81
What is Hyperglycemic Hyperosmolar State (HHS)?
1. Hyperglycemic coma characterized by severe hyperglycemia in absence of significant ketosis 2. Hyperosmolality, change in mental status & dehydration are common 3. Most common in middle age – elderly
82
What are common precipitating events for HHS?
1. Infection 2. MI 3. CVA 4. Recent surgery 5. Dehydration
83
What is the pathophys of HHS?
1. Relative insulin deficiency reduces glucose utilization by muscle, fat and liver -> inappropriate glucagon secretion & hepatic glucose output 2. Leads to massive glycosuria -> marked dehydration 3. Severe hyperosmolality leads to mental confusion -> coma
84
What are the sxs of HHS?
``` 1. Insidious onset over days – weeks: A. Weakness B. Severe dehydration C. Polyuria D. Polydipsia E. Orthostatic hypotension F. Lethargy G. Confusion / delirium H. Neurologic defects (reversible hemiplegia, focal seizures) ```
85
How is HHS diagnosed?
``` 1. Serum glucose A. >800 mg/dL 2. ↑ BUN/Cr 3. Serum Na A. 120-125 mEq/L (mild dehydration) B. > 140 mEq/L (severe dehydration) 4. Serum osmolality A. > 350 mOsm/kg 5. pH A. Normal (7.35-7.45) 6. No acidosis A. Ketones neg 7. Normal anion gap A. 8-10 mEq/L 8. Serum HCO3 normal A. > 12 mEq/L 9. Hypomagnesemia 10. Hypocalcemia 11. Hypophosphatemia ```
86
What is the workup for HHS?
1. Airway, breathing, & circulation (ABC) status 2.Mini Mental status (MMSE) 3. BMP 4. CBC w/diff 5. UA & urine ketones by dipstick 6. Plasma osmolality 7. ABG if serum bicarbonate reduced or hypoxia suspected A. F/U w/venous blood gasses 8. EKG 9. Additional testing A. UC, sputum Cx , BC x 2, serum lipase/amylase, CXR B. Infection (pneumonia or UTI) - common precipitating event
87
What are the fluid replacement guidelines in HHS?
1. 0.45% NS preferred initial fluid A. Due to hyperosmolar body fluid of pt B. Slower rate than in DKA due to co-morbidities C. Use 0.9% NS if hypotensive or serum osmolality < 320 mOsm/L 2. Once blood glucose reaches 250 mg/dl: A. D5W, D51/2 NS, D5NS B. Goal to maintain glycemic levels 250-300 mg/dl to prevent cerebral edema
88
How is insulin and K managed in HHS?
``` 1. Insulin A. Decrease hypergylcemia 2. K A. Since no acidosis, less severe K depletion B. Add 10 meq/L to initial fluid ```
89
What is the prognosis for HHS?
1. Overall mortality rate HHS is > 10x that of DKA A. Esp Elderly w/other co-morbidities 2. When prompt recognition and treatment are initiated, mortality rate can be reduced
Gen Med: Ednocrine
flashcards
Decks in class (8)
# Cards
Brainscape helps you reach your goals faster, through stronger study habits.
© 2026 Bold Learning Solutions. Terms and Conditions